CVE-2025-67645
Open-emr Openemr broken access control
- Published27 Jan 2026
Description
OpenEMR is a free and open source electronic health records and medical practice management application. Versions prior to 7.0.4 have a broken access control in the Profile Edit endpoint. An authenticated normal user can modify the request parameters (pubpid / pid) to reference another user’s record; the server accepts the modified IDs and applies the changes to that other user’s profile. This allows one user to alter another user’s profile data (name, contact info, etc.), and could enable account takeover. Version 7.0.4 fixes the issue.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2025-67645 being actively exploited?
CVE-2025-67645 is not in the CISA KEV catalog. A public exploit reference exists, so treat it as exploitable. Its EPSS exploit probability is 0.39%.
How severe is CVE-2025-67645?
CVE-2025-67645 has a CVSS 3.1 base score of 8.8, rated high. EPSS estimates a 0.39% probability of exploitation.
Which products are affected by CVE-2025-67645?
Affected products include Open-emr Openemr.
How do I fix CVE-2025-67645?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2025-67645 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.